Lexicon Pharmaceuticals
LXRX
#7142
Rank
C$0.70 B
Marketcap
C$1.93
Share price
-1.41%
Change (1 day)
112.21%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Cash on Hand

Cash on Hand as of September 2025 : C$0.16 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has C$0.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lexicon Pharmaceuticals - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.34 B51.42%
2023-12-31C$0.22 B20.12%
2022-12-31C$0.18 B69.83%
2021-12-31C$0.11 B-43.06%
2020-12-31C$0.19 B-45.28%
2019-12-31C$0.35 B62.74%
2018-12-31C$0.21 B-44.2%
2017-12-31C$0.39 B-16.09%
2016-12-31C$0.46 B-35.61%
2015-12-31C$0.72 B83.65%
2014-12-31C$0.39 B186.49%
2013-12-31C$0.13 B-38.07%
2012-12-31C$0.22 B-22.54%
2011-12-31C$0.28 B35.78%
2010-12-31C$0.21 B23.41%
2009-12-31C$0.17 B36.39%
2008-12-31C$0.12 B-51.43%
2007-12-31C$0.25 B177.16%
2006-12-31C$93.14 M-19.75%
2005-12-31C$0.11 B10.37%
2004-12-31C$0.10 B-22.08%
2003-12-31C$0.13 B-8.72%
2002-12-31C$0.14 B-38.03%
2001-12-31C$0.23 B-21.44%
2000-12-31C$0.30 B2199.19%
1999-12-31C$13.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
C$4.2 M-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$11.66 B 7,182.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$0.58 B 266.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.04 B 1,174.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$4.89 B 2,958.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.12 B-20.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$1.76 B 1,002.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.93 B 483.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.23 B 48.74%๐Ÿ‡บ๐Ÿ‡ธ USA